Precise CRISPR-Cas9 genome editing for Pseudomonas putida, from single-gene deletions to iterative strain engineering.
Our service leverages a CRISPR-Cas9 system tailored for Pseudomonas putida, enabling efficient genome modifications from single-gene deletions to iterative multi-locus engineering. The workflow integrates guide RNA design, plasmid construction, transformation, colony screening, and sequence verification — all managed by our experienced team to deliver validated edited strains.
We combine custom gRNA design, single-plasmid CRISPR-Cas9 delivery, and robust assessment to deliver precisely edited strains for your research or production goals.
We design gRNAs and construct the all-in-one plasmid, then transform into P. putida for editing.
Edits are confirmed by PCR and Sanger sequencing across the target locus.
The single-plasmid system allows easy curing between cycles, enabling sequential modifications in the same strain.
Both small deletions and targeted insertions (up to several kb) are achievable via homology-directed repair templates.
Each edited clone is sequence-verified; off-target analysis is available as an optional add-on.
Standard deliverables include sequence-confirmed edited strains and project documentation. Additional options extend your analysis.
| Parameter | Typical project scope |
|---|---|
| Edit Type | Gene deletion, insertion, and replacement (scoped per project after consultation) |
| Donor Template | Synthetic DNA with homology arms (length and design scoped per project) |
Our five-step process ensures efficient and accurate genome editing in Pseudomonas putida.
We design specific sgRNAs targeting your gene of interest, with on-target efficiency and off-target potential evaluated computationally.
A single-plasmid expressing Cas9 and the sgRNA, along with a homology-directed repair template when needed, is assembled and sequence-verified.
The plasmid is transformed into P. putida via electroporation; edited cells are selected using antibiotic or fluorescent markers.
Individual colonies are screened by colony PCR to identify those carrying the desired edit at the target locus.
Editing is confirmed by Sanger sequencing, then the CRISPR plasmid is cured to enable a clean strain for subsequent rounds or applications.
Our Pseudomonas putida genome editing service supports metabolic engineering, functional genomics, and biocontainment projects.
Our service supports targeted knockout of competing pathways or insertion of biosynthetic genes.
Generate precise deletion mutants to investigate gene essentiality and phenotype.
Design CRISPR-based kill switches or auxotrophic markers for safe industrial strains.
Turnaround is scoped per project based on edit complexity and number of clones required. We provide a timeline during the project consultation and confirm it in the SOW.
Editing is confirmed by colony PCR screening followed by Sanger sequencing of the target region. We sequence both junctions and the full edited locus to support correct modification. For insertions, we investigate presence and correct orientation of the inserted sequence. Plasmid curing is confirmed by loss of antibiotic resistance and further PCR.
Yes, the single-plasmid system is designed for rapid curing between rounds. After one edit is verified and the plasmid cured, a new CRISPR plasmid targeting the next locus can be introduced. This iterative approach allows sequential addition or removal of genes without leaving residual selection markers.
Turnaround depends on the complexity of the edit and the number of clones needed. For a standard gene deletion with one target clone, the timeline is scoped during project consultation. We aim to provide sequence-verified constructs with strain confirmation scoped per project a timeline confirmed during project scoping, but exact timelines are confirmed in the project SOW based on your specific requirements.
Get a customized quote for your Pseudomonas putida CRISPR-Cas9 Genome Editing project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.